ANEURYSMAL SUBARACHNOID HEMORRHAGE: IS THE TIME UNTIL INTERVENTION RELATED TO MINOR DISABILITIES IN 6 MONTHS?


LC-MS/MS-based serum proteomics reveals a distinctive signature in a rheumatoid arthritis mouse model after treatment with mesenchymal stem cells.

Mesenchymal stem cells (MSCs) are known to be able to modulate immune responses, possess tissue-protective properties, and exhibit healing capacities with therapeutic potential for various diseases.The ability of MSCs to secrete various cytokines and growth factors provides new insights into autoimmune-diseases such as rheumatoid arthritis (RA).RA

read more